TerrAscend Corp (TED) - Total Assets

Latest as of December 2025: €557.38 Million EUR ≈ $651.63 Million USD

Based on the latest financial reports, TerrAscend Corp (TED) holds total assets worth €557.38 Million EUR (≈ $651.63 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check TED cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

TerrAscend Corp - Total Assets Trend (2016–2025)

This chart illustrates how TerrAscend Corp's total assets have evolved over time, based on quarterly financial data. Explore long-term investment intensity of TerrAscend Corp to see how much of total assets are deployed in long-term investments.

TerrAscend Corp - Asset Composition Analysis

Current Asset Composition (December 2025)

TerrAscend Corp's total assets of €557.38 Million consist of 19.8% current assets and 80.3% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 6.7%
Accounts Receivable €15.14 Million 2.7%
Inventory €34.05 Million 6.1%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €167.31 Million 30.0%
Goodwill €109.77 Million 19.7%

Asset Composition Trend (2016–2025)

This chart illustrates how TerrAscend Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see TerrAscend Corp (TED) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: TerrAscend Corp's current assets represent 19.8% of total assets in 2025, a decrease from 89.6% in 2016.
  • Cash Position: Cash and equivalents constituted 6.7% of total assets in 2025, down from 86.2% in 2016.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 0.0% in 2016.
  • Asset Diversification: The largest asset category is intangible assets at 30.0% of total assets.

TerrAscend Corp Competitors by Total Assets

Key competitors of TerrAscend Corp based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Sweden Skr81.26 Billion
Aurobindo Pharma Limited
NSE:AUROPHARMA
India Rs585.02 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥14.18 Billion
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
China CN¥19.57 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
China CN¥10.37 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
China CN¥7.28 Billion
Xeris Pharmaceuticals Inc
NASDAQ:XERS
USA $392.01 Million
Procter & Gamble Health Limited
NSE:PGHL
India Rs8.94 Billion

TerrAscend Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.38 1.94 3.03
Quick Ratio 0.95 1.51 2.46
Cash Ratio 0.00 0.00 0.00
Working Capital €30.18 Million €85.84 Million €206.50 Million

TerrAscend Corp - Advanced Valuation Insights

This section examines the relationship between TerrAscend Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.45
Latest Market Cap to Assets Ratio 0.35
Asset Growth Rate (YoY) -8.2%
Total Assets €557.38 Million
Market Capitalization $197.60 Million USD

Valuation Analysis

Below Book Valuation: The market values TerrAscend Corp's assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: TerrAscend Corp's assets decreased by 8.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for TerrAscend Corp (2016–2025)

The table below shows the annual total assets of TerrAscend Corp from 2016 to 2025.

Year Total Assets Change
2025-12-31 €557.38 Million
≈ $651.63 Million
-8.21%
2024-12-31 €607.23 Million
≈ $709.92 Million
-8.90%
2023-12-31 €666.52 Million
≈ $779.23 Million
-5.00%
2022-12-31 €701.59 Million
≈ $820.23 Million
+20.56%
2021-12-31 €581.93 Million
≈ $680.34 Million
-3.63%
2020-12-31 €603.88 Million
≈ $706.00 Million
+31.06%
2019-12-31 €460.77 Million
≈ $538.68 Million
+417.84%
2018-12-31 €88.98 Million
≈ $104.02 Million
+28.84%
2017-12-31 €69.06 Million
≈ $80.74 Million
+1685.83%
2016-12-31 €3.87 Million
≈ $4.52 Million
--

About TerrAscend Corp

F:TED Germany Drug Manufacturers - Specialty & Generic
Market Cap
$197.60 Million
€169.02 Million EUR
Market Cap Rank
#16691 Global
#1580 in Germany
Share Price
€0.55
Change (1 day)
-1.80%
52-Week Range
€0.17 - €1.09
All Time High
€13.10
About

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries und… Read more